application

No issues with clinical efficacy or safety, trial design, labeling or drug substance manufacturing were identified in the CRL No additional clinical data or trials have been requested…

LONDON and RALEIGH, N.C., June 27, 2023 (GLOBE NEWSWIRE) -- Verona Pharma plc (Nasdaq: VRNA) (“Verona Pharma” or the “Company”) announces the submission of a New Drug Application (“NDA”)…

Austin, TX, USA, June 26, 2023 (GLOBE NEWSWIRE) -- Custom Market Insights has published a new research report titled “Wearable Skin Adhesives Market Size, Trends and Insights By Product…

ST. LOUIS, June 15, 2023 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today announced…

The 2024 electronic residency application service (ERAS) season is scheduled to…

WALTHAM, Mass., June 06, 2023 (GLOBE NEWSWIRE) -- TScan Therapeutics, Inc. (Nasdaq: TCRX), a clinical-stage biopharmaceutical company focused on the development of T cell receptor…

PUNE, June 05, 2023 (GLOBE NEWSWIRE) -- "Neonatal Ventilators Market" | No. of pages: 99|research report focus on overall information that can help to take decisions on current market…

BOSTON, May 30, 2023 (GLOBE NEWSWIRE) -- PepGen Inc. (Nasdaq: PEPG), a clinical-stage biotechnology company advancing the next generation of oligonucleotide therapies with the goal of…

Priority Review Granted withPrescription Drug User Fee Act (PDUFA) Action Date of November 25, 2023 First Potential Approval of an Individualized, One-Time Cell Therapy for Patients…

<!-- Name:DistributionId Value:8847048 --> <!-- Name:EnableQuoteCarouselOnPnr Value:False -->…